Cargando...
Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes
Although clozapine has demonstrated superior efficacy in patients with schizophrenia and other serious mental health illness, drug utilization rates are significantly low due to safety concerns and administration challenges. Previous research indicates that current barriers to clozapine use include...
Gardado en:
| Publicado en: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6708436/ https://ncbi.nlm.nih.gov/pubmed/31692521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S216803 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|